T-CiRA: Unique Industry-Academia Collaboration to Accelerate iPS Cell Technologies for Clinical Applications

6/19/2018
10:40 - 11:10

Seigo Izumo

Dr. Seigo Izumo is Senior Vice President, Global Head of Regenerative Medicine Unit and Head of Scientific Affairs in Japan at Takeda Pharmaceutical Company. Previously he served as Senior VP & Head of Cardiovascular Therapeutics at Gilead Sciences, and VP & Global Head of Cardiovascular Research at Novartis. Prior to joining the industry, Dr. Izumo was Professor of Medicine, Harvard Medical School and Director of Cardiovascular Research, Beth Israel Deaconess Medical Center, Boston, and Chief of Cardiology Division, Professor of Internal Medicine & Biological Chemistry and Director of the Center for Organogenesis, University of Michigan Medical School. Dr. Izumo graduated from University of Tokyo and received clinical and research trainings at Harvard-affiliated Beth Israel Hospital and The Children's Hospital, Boston. He is a board-certified physician in internal medicine and cardiovascular disease.

Presentation(s):

Send Email for Seigo Izumo


Assets

T-CiRA: Unique Industry-Academia Collaboration to Accelerate iPS Cell Technologies for Clinical Applications



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for T-CiRA: Unique Industry-Academia Collaboration to Accelerate iPS Cell Technologies for Clinical Applications